個案資料
了解個案內容與學習目標，選擇授課教師及使用課程。
ImmuLogic Pharmaceutical Corp. (Abridged)
內容大綱
ImmuLogic Pharmaceutical Corp., a development-stage biotechnology company, is considering making an initial offering of common stock. The rationales for and problems of high-technology start-ups are explored. The challenges posed by "windows" for public offerings are highlighted.